Role of Smad1 and Smad4 proteins in the induction of p21WAF1,Cip1 during bone morphogenetic protein-induced growth arrest in human breast cancer cells

Journal of Endocrinology

Volumn 172, Issue 1, 2002, Pages 187-198

  Pouliot, F ^a   Labrie, C ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN RECEPTOR; CYCLOHEXIMIDE; DACTINOMYCIN; ESTROGEN; GROWTH PROMOTOR; LUCIFERASE; MESSENGER RNA; PROTEIN; PROTEIN P21; RECOMBINANT PROTEIN; SMAD PROTEIN; SMAD1 PROTEIN; SMAD4 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BASE PAIRING; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CARBOXY TERMINAL SEQUENCE; CELL PROLIFERATION; CONTROLLED STUDY; GENETIC TRANSCRIPTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MEDIATOR; PEPTIDE MAPPING; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN INDUCTION;

BLOTTING, NORTHERN; BONE MORPHOGENETIC PROTEINS; BREAST NEOPLASMS; CELL DIVISION; CELL LINE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; CYCLOHEXIMIDE; DACTINOMYCIN; DEPRESSION, CHEMICAL; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOBLOTTING; RNA, MESSENGER; SMAD PROTEINS; SMAD1 PROTEIN; SMAD4 PROTEIN; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0036148661     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1720187     Document Type: Article

References (46)

1. Identification of bone morphogenetic proteins and their receptors in human breast cancer cell lines: Importance of BMP2
2. Smads as transcriptional co-modulators
3. Cooperation of Sp1 and p300 in the induction of the CDK inhibitor p21 WAF1/CIP1 during NGF-mediated neuronal differentiation
4. Structure of the gene encoding the human cyclin-dependent kinase inhibitor p18 and mutational analysis in breast cancer
5. Regulation of plasminogen activator inhibitor-1 expression by transforming growth factor-beta-induced physical and functional interactions between Smads and Sp1
6. Functional analysis of the transforming growth factor beta responsive elements in the WAF1/Cip1/p21 promoter
7. Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism
8. Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta
9. A general, fast, and sensitive micromethod for DNA determination - Application to rat and mouse liver, rat hepatoma, human leukocytes, chicken fibroblasts, and yeast cells
10. Bone morphogenetic protein-2 induces cyclin kinase inhibitor p21 and hypophosphorylation of retinoblastoma protein in estradiol-treated MCF-7 human breast cancer cells
11. Bone morphogenetic protein-2 blocks MDA-MB-231 human breast cancer cell proliferation by inhibiting cyclin-dependent kinase-mediated retinoblastoma protein phosphorylation
12. Lovastatin induction of cyclin-dependent kinase inhibitors in human breast cells occurs in a cell cycle-independent fashion
13. Cancer Statistics, 2001. CA-A
14. Bone morphogenetic proteins in human bone regeneration
15. p15 INK4B is a potential effector of TGF-beta-induced cell cycle arrest
16. OAZ uses distinct DNA- and protein-binding zinc fingers in separate BMP-Smad and Olf signaling pathways
17. Smad1 and Smad4 are components of the bone morphogenetic protein-4 (BMP-4)-induced transcription complex of the Xvent-2B promoter
18. Molecular mechanisms of transforming growth factor-beta signaling
19. Smad6 is a Smad1/5-induced smad inhibitor - Characterization of bone morphogenetic protein-responsive element in the mouse Smad6 promoter
20. Differential inhibition of Smad6 and Smad7 on bone morphogenetic protein- and activin-mediated growth arrest and apoptosis in B cells
21. Interaction of Smad complexes with tripartite DNA-binding sites
22. Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-beta, activin, and bone morphogenetic protein-inducible enhancer
23. Bone morphogenetic protein-2 induces apoptosis in human myeloma cells with modulation of STAT3
24. The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase
25. A human Mad protein acting as a BMP-regulated transcriptional activator
26. Transforming growth factor beta signaling through Smad1 in human breast cancer cells
27. Androgen induction of cyclin-dependent kinase inhibitor p21 gene: Role of androgen receptor and transcription factor Sp1 complex
28. TGF-beta signal transduction
29. Transcriptional control by the TGF-beta/Smad signaling system
30. TGF-beta signaling in growth control, cancer, and heritable disorders
31. TGF-beta signaling by Smad proteins
32. Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members
33. Progesterone regulates transcription of the p21(WAF1) cyclin-dependent kinase inhibitor gene through Sp1 and CBP/p300
34. Role of Smad proteins and transcription factor Sp1 in p21 WAF-1/Cip-1 regulation by transforming growth factor-beta
35. The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation
36. Regulation of Msx-1, Msx-2, Bmp-2 and Bmp-4 during foetal and postnatal mammary gland development
37. Sp1 and Smad proteins cooperate to mediate TGF-beta1-induced alpha2(I) collagen expression in human glomerular mesangial cells
38. Expression profile of agonistic Smads in human breast cancer cells: Absence of regulation by estrogens
39. The subcellular locations of p15(Ink4b) and p27(Kip1) coordinate their inhibitory interactions with cdk4 and cdk2
40. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta
41. DPC4/SMAD4 gene alterations in human cancer, and their functional implications
42. Inhibitors of mammalian G1 cyclin-dependent kinases
43. CDK inhibitors: Positive and negative regulators of G1-phase progression
44. Characterisation of the effects of the novel non-steroidal antiestrogen EM-800 on basal and estrogen-induced proliferation of T-47D, ZR-75-1 and MCF-7 human breast cancer cells in vitro
45. Sp3, but not Sp1, mediates the transcriptional activation of the p21/WAF1/Cip1 gene promoter by histone deacetylase inhibitor
46. The mycotoxin fumonisin B1 transcriptionally activates the p21 promoter through a cis-acting element containing two Sp1 binding sites